Introduction
============

Eosinophilic dermatosis of hematologic malignancy was first reported in 1965 and thought to be a hypersensitivity reaction to insect bites in patients with chronic lymphocytic leukemia (CLL) \[[@b1-dp0703a02]\]. Subsequent reports noted that most patients failed to recall insect bites; thus, the term "insect bite-like reaction" was established \[[@b2-dp0703a02]\]. Byrd et al. later dubbed the process eosinophilic dermatosis of myeloproliferative disease \[[@b3-dp0703a02]\], though Farber et al. favor the term eosinophilic dermatosis of hematologic malignancy to better encompass the numerous hematologic malignancies associated with this cutaneous eruption \[[@b4-dp0703a02],[@b5-dp0703a02]\]. We describe a woman with CLL whose lesions resembled varicella zoster virus infection and review the literature on eosinophilic dermatosis of hematologic malignancy.

Case Report
===========

A 59-year-old woman with CLL presented for evaluation of vesicular eruptions thought to be recurrent varicella zoster virus infection. She was diagnosed with CLL in 2003 but experienced several recurrences of her leukemia. Shortly after the first recurrence of CLL in 2009, she developed skin lesions that appeared in a dermatomal distribution on her back. These lesions reappeared several times, and her oncologist treated her for presumptive herpes zoster virus infection with an appropriate dosage of acyclovir on more than 20 occasions. The patient had no definitive prior history of herpes zoster virus infection; varicella zoster virus infection had never been objectively confirmed with biopsy, viral culture, or PCR amplification. However, the patient did have several complete blood counts drawn. Eosinophil percentages ranged from 1--10%, though most frequently were 4--5% (normal range 0--7%); however, absolute eosinophil count never exceeded 500 cells per ml (normal range 0--500 cells per ml). Serum IgE level was assessed and found to be 2 International Units (IU) per ml (normal range 0--99 IU/ml). Her CLL therapy initially included fludarabine, cyclophosphamide, and rituximab but later included alemtuzumab, lenalidomide, venetoclax, and obinutuzumab.

She presented to the dermatologist for evaluation of a new onset of her skin lesions; these were similar to those that her oncologist had previously treated as varicella zoster virus infection outbreaks. Cutaneous examination showed dermatomal ([Figure 1](#f1-dp0703a02){ref-type="fig"}) and non-dermatomal ([Figure 2](#f2-dp0703a02){ref-type="fig"}) lesions with similar morphology on her back and flanks. Vesicles ranging from 2 mm to 5 mm, within areas of erythema, were present. Initial evaluation included viral cultures for herpes simplex virus and varicella zoster virus; vesicular fluid was sent for direct fluorescent antibody to these viruses. In addition, biopsies were performed for both routine staining and direct immunofluorescence to rule out autoimmune bullous diseases.

The viral cultures and direct fluorescent antibody studies were negative. Microscopic examination of the skin biopsy showed an intraepidermal vesicle with eosinophils, eosinophilic spongiosis, and an accompanying diffuse and dense perivascular and periadnexal lymphocytic infiltrate with numerous eosinophils ([Figure 3](#f3-dp0703a02){ref-type="fig"}). Direct immunofluorescence and enzyme-linked immunosorbent assay (ELISA) studies were negative for bullous pemphigoid antigen-1 and bullous pemphigoid antigen-2.

Correlation of the clinical history, morphology, pathologic changes, and laboratory studies established the diagnosis of eosinophilic dermatosis of hematologic malignancy. Initial management included twice daily application of betamethasone dipropionate 0.05% cream, which provided relief and eventual resolution of the lesions. Two weeks later, the patient had recurrence of her lesions ([Figure 4](#f4-dp0703a02){ref-type="fig"}) and another skin biopsy showed similar pathologic changes. The patient was receiving investigational systemic therapy for her CLL; oral and other systemic therapies were prohibited. She continued her topical treatment.

The frequency of relapsing skin lesions was markedly reduced during periods in which the patient's hematologic malignancy was under better control. Recently, she had an exacerbation of her CLL and antineoplastic therapy was altered. Subsequently, she has had less frequent flares of her dermatosis after being placed on obinutuzumab.

Discussion
==========

Patients with CLL usually present with eosinophilic dermatosis of hematologic malignancy between 40 to 60 years of age \[[@b4-dp0703a02]\]. [Table 1](#t1-dp0703a02){ref-type="table"} offers a review of this condition \[[@b1-dp0703a02]--[@b25-dp0703a02]\]. The eruption often occurs concurrently with or months to years after the diagnosis of the associated hematologic malignancy. However, the condition has also been reported to present prior to the cancer diagnosis \[[@b4-dp0703a02]\].

Eosinophilic dermatosis of hematologic malignancy occurs most often with CLL. It has also been associated with acute lymphoblastic leukemia, acute monocytic leukemia, large cell lymphoma, mantle cell lymphoma, multiple myeloma, and myelofibrosis \[[@b4-dp0703a02],[@b6-dp0703a02],[@b7-dp0703a02]\].

Eosinophilic dermatosis of hematologic malignancy has a polymorphic presentation. The condition may manifest as erythema, papules, nodules, urticaria, or vesicles \[[@b4-dp0703a02],[@b9-dp0703a02]\]. The eruption is usually indurated and erythematous but can also be tender \[[@b4-dp0703a02]\]. The clinical differential diagnosis includes arthropod assault, dermatitis herpetiformis, drug reaction, eosinophilic cellulitis, eosinophilic folliculitis, infection, leukemia cutis, papular urticaria, scabies, and urticarial stage of bullous pemphigoid \[[@b4-dp0703a02],[@b9-dp0703a02]\].

Histologically, this condition displays a superficial and deep dense perivascular infiltrate of lymphocytes and eosinophils \[[@b2-dp0703a02],[@b4-dp0703a02]\]. Vesicles or bullae may also present due to intraepidermal or subepidermal edema \[[@b4-dp0703a02]\]. Flame figures in the dermis have also been reported \[[@b5-dp0703a02]\].

The pathogenesis of this condition is poorly understood \[[@b4-dp0703a02]\]. It has been hypothesized that there is an excess of interleukin-4 and interleukin-5; this imbalance may lead to a proliferation of neoplastic B cells, which have been considered a major driver of the eruption \[[@b3-dp0703a02],[@b4-dp0703a02],[@b9-dp0703a02]\]. This hypothesis is supported by the fact that interleukin-5 is the major eosinophil-recruiting cytokine \[[@b4-dp0703a02]\]. Alternatively, it has been thought that neoplastic B cells drive a hypersensitivity reaction \[[@b3-dp0703a02]\].

Several therapeutic options to treat eosinophilic dermatosis of hematologic malignancy have been reported. They include antibiotics, antihistamines, chemotherapy, dapsone, interferon alpha, intravenous immunoglobulin, phototherapy, and radiation \[[@b2-dp0703a02],[@b4-dp0703a02],[@b10-dp0703a02]\]. Though some patients report favorable responses to therapy, overall the results have been disappointing \[[@b4-dp0703a02]\]. The poor response underscores the lack of clarity of this condition's pathogenesis \[[@b4-dp0703a02]\].

In regards to prognosis, eosinophilic dermatosis of hematologic malignancy may be associated with an aggressive course of CLL \[[@b4-dp0703a02]\]; our patient lends support to this observation, given her repeat recurrences of CLL. Reported complications in patients with CLL and eosinophilic dermatosis of hematologic malignancy include Richter transformation and malignant clone expansion \[[@b2-dp0703a02],[@b10-dp0703a02]\]. An underlying state of immunosuppression is postulated as the cause for these occurrences.

Conclusion
==========

Our patient's recurrent skin lesions of eosinophilic dermatosis of hematologic malignancy were clinically interpreted by her oncologist to be varicella zoster virus infection because they were frequently dermatomal. However, the likelihood of over 20 episodes of herpes zoster would be unique and unexpected; hence, we were prompted to evaluate her skin lesions and exclude the diagnosis of either a viral infection or autoimmune bullous disease. It is conceivable that our patient may have initially had zoster sine herpete, which manifests as radicular pain without rash \[[@b26-dp0703a02]\]. With a background of zoster sine herpete, the patient plausibly could have developed an immunocompromised zone and therefore displayed Wolf's isotopic response, in which a new skin disorder occurs at the site of a previously healed skin disease \[[@b27-dp0703a02]\]. However, our investigation established the diagnosis of eosinophilic dermatosis of hematologic malignancy. Based on our patient's morphologic presentation of eosinophilic dermatosis of hematologic malignancy, we add disseminated zoster infection with dermatomal and non-dermatomal distribution to the differential diagnosis of this condition.

**Funding:** None.

**Competing interests:** The authors have no conflicts of interest to disclose.

All authors have contributed significantly to this publication.

![Distant views of vesicles on an erythematous base corresponding to the left T6 dermatome presenting below the breast (A), and extending to involve the upper abdomen and mid-back (B). \[Copyright: ©2017 Bari et al.\]](dp0703a02g001){#f1-dp0703a02}

![Distant (A) and close (B) views of an isolated, non-dermatomal, erythematous-based vesicle appears on the lower left flank. \[Copyright: ©2017 Bari et al.\]](dp0703a02g002){#f2-dp0703a02}

![Microscopic examination of a low magnification view showing a large vesicle (A). Intermediate magnification views (B and C) of the lateral aspects of the vesicle demonstrating that it is intraepidermal and contains serosanguinous fluid with eosinophils. The base of the blister shows eosinophilic spongiosis (D); the spaces between keratinocytes are filled with eosinophils. In the underlying dermis, there is edema and a dense infiltrate that is not only diffuse but also perivascular and periadnexal; the infiltrate consists of lymphocytes and numerous eosinophils (D and E) (hematoxylin and eosin; a = x4; b = x20; c = x20; d = x20; and e = x40). \[Copyright: ©2017 Bari et al.\]](dp0703a02g003){#f3-dp0703a02}

![Distant (A) and closer (B and C) views of a linear presentation of erythematous-based vesicles of eosinophilic dermatosis of hematologic malignancy corresponding to the left L4 dermatome. \[Copyright: ©2017 Bari et al.\]](dp0703a02g004){#f4-dp0703a02}

###### 

Summary of eosinophilic dermatosis of hematologic malignancy \[Copyright: ©2017 Bari et al.\]

  Author, Year           Number of Cases   Associated Malignancy                      Age; Sex             Clinical Manifestation                                                                                                                                                                                       Histology                                                                                                                                                                                                    Management                                                                                                                                                                                                                 EDHM Course                                                                                                                                                                                                           Ref
  ---------------------- ----------------- ------------------------------------------ -------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------
  Weed, 1965             8                 CLL                                        40--76; NR           Erythematous, indurated, and pruritic lesions in areas of recent mosquito bites or areas with central punctum                                                                                                Subepidermal edema with dense dermal infiltrate of eosinophils and lymphocytes                                                                                                                               CLL was treated with chlorambucil or prednisone in most patients                                                                                                                                                           Lesions resolved spontaneously within weeks                                                                                                                                                                           [@b1-dp0703a02]
  Rosen, 1986            10                CLL                                        57--82; 7 M, 3 W     Erythematous and pruritic bullae, nodules, and papules at various locations                                                                                                                                  Superficial and deep, perivascular, periadnexal, and interstitial infiltrate of eosinophils and lymphocytes                                                                                                  Treatments for CLL included prednisone, vincristine, cyclophosphamide, and chlorambucil                                                                                                                                    NR                                                                                                                                                                                                                    [@b11-dp0703a02]
  Kolbusz, 1989          1                 CLL                                        51; W                Recurrent eruptions of erythematous urticarial patches on the extremities and trunk                                                                                                                          Lymphohistiocytic infiltrate with eosinophils                                                                                                                                                                Diphenhydramine for skin lesions                                                                                                                                                                                           Initial outbreaks were self-limited with no treatment; later eruptions improved with diphenhydramine                                                                                                                  [@b12-dp0703a02]
  Davis, 1998            8                 CLL                                        51--69; 6 M, 2 W     Papular and vesiculobullous lesions in various locations                                                                                                                                                     All biopsies revealed lymphohistioctic infiltrate and eosinophils in the dermis                                                                                                                              Chemotherapy, IVIG, and glucocorticoids                                                                                                                                                                                    3 patients experienced improvement with chemotherapy for CLL; 1 patient improved with IVIG; 4 patients responded to oral glucocorticoids                                                                              [@b10-dp0703a02]
  Barzilai, 1999         8                 ALL, AML, CLL (3 patients), MCL, LCL, MF   42--72; 4 M, 4 W     Recurrent erythematous, pruritic papules and plaques at various locations                                                                                                                                    Superficial and deep perivascular and interstitial infiltrate of eosinophils and lymphocytes                                                                                                                 Topical antipruritic agents, topical and systemic corticosteroids, systemic antihistamines                                                                                                                                 No improvement with any agent except systemic corticosteroids, though lesions recurred when steroids were tapered                                                                                                     [@b2-dp0703a02]
  Blum, 2001             1                 CLL                                        49; M                Admitted to the hospital after second cycle of chemotherapy with vesicles and hemorrhagic bullae on the extremities, face, and trunk                                                                         Superficial and deep perivascular dermatitis with interstitial eosinophils                                                                                                                                   Systemic corticosteroids                                                                                                                                                                                                   Lesions improved with steroids but recurred with tapered dose                                                                                                                                                         [@b13-dp0703a02]
  Byrd, 2001             4                 AML, CLL (2 patients), MDS                 53--81; 4 M          Recurrent eruptions of erythematous, pruritic nodules and papules at various locations                                                                                                                       Perivascular and periadnexal infiltrate with lymphocytes and eosinophils                                                                                                                                     Antibiotics, antifungals, antihistamines, colchicine, dapsone, hydroxyurea, hydroxychloroquine, isotretinoin, systemic and topical steroids, and UV-B phototherapy for skin lesions; chemotherapy started for malignancy   2 patients' lesions resolved during chemotherapy but recurred once it was complete, and chemotherapy was re-started to control skin lesions in these patients; 2 patients experienced improvement with phototherapy   [@b3-dp0703a02]
  Asakura, 2004          1                 CLL                                        46; W                Pruritic, erythematous bullae on the extremities in the site of prior mosquito bites                                                                                                                         NR                                                                                                                                                                                                           Cyclophosphamide and prednisolone for CLL                                                                                                                                                                                  Skin lesions were self-limited                                                                                                                                                                                        [@b14-dp0703a02]
  Cocuroccia, 2004       1                 CLL                                        65; M                4-month history of recurrent pruritic bullae and papules on the extremities                                                                                                                                  Epidermal spongiosis, edema in papillary dermis, with superficial and deep, perivascular and interstitial infiltrate of eosinophils and neutrophils                                                          Antihistamines and topical corticosteroids for skin lesions                                                                                                                                                                Improvement after 10 days with mild recurrence after 2 weeks; no further lesions at 6-month follow-up                                                                                                                 [@b15-dp0703a02]
  Dodiuk-Gad, 2004       2                 MCL                                        61, 64; 2 M          Patient 1 with 6-month duration of pruritic, erythematous nodules and papules on the extremities; Patient 2 with 2-year history of pruritic, erythematous nodules, papules, and plaques on the extremities   Patient 1 with epidermal spongiosis and microvesicles with eosinophils, along with an upper dermal infiltrate of eosinophils; Patient 2 with dense infiltrate of eosinophils and neutrophils in the dermis   Antipruritic agents, topical and oral steroids for skin lesions in Patient 1; Patient 2 started on CHOP and rituximab                                                                                                      Patient 1 improved with oral prednisone but lesions continued to recur; Patient 2 improved with chemotherapy                                                                                                          [@b16-dp0703a02]
  Khamaysi, 2005         6                 CLL (3 patients) and MCL (3 patients)      56--74; 3 M, 3 W     Pruritic and erythematous nodules, papules, plaques, and vesicles                                                                                                                                            Superficial and deep perivascular and interstitial infiltrate with eosinophils and mononuclear cells                                                                                                         NR                                                                                                                                                                                                                         NR                                                                                                                                                                                                                    [@b17-dp0703a02]
  Vassallo, 2005         5                 CLL (3 patients), NHL (2 patients)         NR; NR               Erythematous, pruritic bullae, papules, and plaques                                                                                                                                                          Superficial and deep perivascular and interstitial infiltrate of eosinophils and lymphocytes                                                                                                                 Antihistamines and systemic steroids for skin lesions                                                                                                                                                                      Improvement in skin lesions but flares continued to recur                                                                                                                                                             [@b18-dp0703a02]
  Yoon, 2005             1                 NMZL                                       46; M                6-year history of recurrent papulovesicular eruptions at various locations                                                                                                                                   Epidermal spongiosis with focal necrosis, edema in the papillary dermis, and perivascular, periadnexal, and interstitial infiltrate of eosinophils, lymphocytes, and neutrophils                             6 courses of CHOP                                                                                                                                                                                                          Improvement in skin lesions with residual scar                                                                                                                                                                        [@b19-dp0703a02]
  Walker, 2007           1                 CLL                                        69; W                18-month history of pruritic, erythematous plaques on the extremities                                                                                                                                        Spongiotic vesiculation and infiltrate of eosinophils in the papillary dermis                                                                                                                                Antibiotics, fexofenadine, ibuprofen, oral prednisolone, promethazine, and topical betamethasone for skin lesions; rituximab for CLL                                                                                       Poor response to all agents except ibuprofen and prednisolone, which reduced severity of outbreaks; once patient was switched to rituximab, she experienced less frequent flares                                      [@b20-dp0703a02]
  Rodríguez-Lojo, 2010   1                 CLL                                        63; M                1-year history of recurrent urticarial nodules on the extremities and trunk                                                                                                                                  Infiltrate of eosinophils that involved fat lobules; later biopsies revealed dermal eosinophilic infiltrate with flame figures                                                                               Systemic steroids, topical steroids, and dapsone for skin lesions; CHOP for CLL                                                                                                                                            Recurrences were reduced with therapy for skin lesions; eruptions stopped when CLL was controlled                                                                                                                     [@b21-dp0703a02]
  Bairey, 2012           48                CLL                                        33--82; 25 M, 23 F   Erythematous and pruritic macules, nodules, papules, and vesicles at various locations                                                                                                                       Superficial and deep, interstitial and perivascular infiltrates of eosinophils and mononuclear cells                                                                                                         Antibiotics, antihistamines, dapsone, oral and topical steroids, phototherapy                                                                                                                                              60% of eruptions resolved with treatment, 24% improved, and 14% had no response to therapy                                                                                                                            [@b22-dp0703a02]
  Farber, 2012           1                 CLL                                        73; M                4-year history of recurrent erythematous, pruritic nodules and papules on the extremities, face, neck, scalp, and trunk                                                                                      Dense superficial and deep perivascular infiltrate of eosinophils and lymphocytes                                                                                                                            Doxycycline, hydroxyzine, and prednisone taper for skin lesions; chemotherapy started for CLL                                                                                                                              Eruptions improved when chemotherapy started but recurred once it was completed; number of lesions and intensity of pruritus decreased but complete resolution was not achieved                                       [@b4-dp0703a02]
  Mitteldorf, 2012       1                 CLL                                        71; F                Pruritic, erythematous papulovesicular eruptions on the face and trunk                                                                                                                                       Focal epidermal spongiosis, edema within the papillary dermis, and superficial and deep perivascular and interstitial infiltrate of eosinophils and lymphocytes                                              Prednisolone for skin lesions; rituximab and bendamustine started for CLL                                                                                                                                                  No cutaneous improvement from chemotherapy; steroids led to complete resolution of skin lesions                                                                                                                       [@b23-dp0703a02]
  Qiao, 2013             1                 CLL                                        67; W                9-month history of recurrent pruritic eruptions of bullae, papules, plaques, and vesicles on the extremities, face, and trunk                                                                                Prominent subepidermal blisters with diffuse infiltrate of eosinophils and flame figures in the dermis                                                                                                       Prednisone                                                                                                                                                                                                                 Lesions improved within 10 days of prednisone but eruption recurred with steroid taper                                                                                                                                [@b5-dp0703a02]
  Butzmann, 2014         1                 CLL                                        60; W                6-month history of lesions on the extremities; presented with excoriated papules and vesicles                                                                                                                Intraepidermal vesicle with eosinophils; dermis with dense perivascular lymphocytic infiltrate with eosinophils                                                                                              Topical corticosteroids and oral antihistamines                                                                                                                                                                            Reduced recurrence rate and intensity of new lesions                                                                                                                                                                  [@b24-dp0703a02]
  Two, 2014              1                 MM                                         50; M                3-month history of pruritic vesicles on the extremities and trunk                                                                                                                                            Superficial and deep mixed perivascular infiltrate of eosinophils and lymphocytes                                                                                                                            Topical corticosteroids for skin lesions; bortezomib, carfilzomib, and dexamethasone for MM                                                                                                                                Vesicles disappeared at 6-week follow-up after stopping topical steroids though MM was undergoing continued therapy                                                                                                   [@b6-dp0703a02]
  Liu, 2015              1                 CLL                                        45; W                5-year history of recurrent pruritic blisters, papules, and plaques on the extremities and face                                                                                                              Subepidermal edema with dense nodular and interstitial infiltrate of eosinophils and lymphocytes in the dermis and subcutaneous tissue                                                                       Prednisolone for 12 months                                                                                                                                                                                                 Lesions continued to recur                                                                                                                                                                                            [@b25-dp0703a02]
  Penn, 2015             1                 DLBCL                                      56; W                Pruritic papular eruptions on the extremities                                                                                                                                                                Superficial and deep perivascular infiltrate of eosinophils and lymphocytes                                                                                                                                  Antihistamines, intralesional glucocorticoids, and topical glucocorticoids for skin lesions; rituximab and bendamustine for CLL                                                                                            Eruptions improved with systemic therapy for malignancy along with regimen of antihistamines and steroids                                                                                                             [@b7-dp0703a02]
  Jayasekera, 2016       1                 CLL                                        51; M                Several week history of papules and plaques on the extremities                                                                                                                                               Epidermal spongiosis and interstitial infiltrate of eosinophils                                                                                                                                              Topical betamethasone, dapsone, oral prednisolone with topical clobetasol; idelalisib and rituximab for CLL                                                                                                                Failed topical steroids; rash flared once oral prednisolone was tapered                                                                                                                                               [@b9-dp0703a02]
  Martires, 2016         1                 CLL                                        68; W                5-month history of recurrent pruritic bullae on the extremities and face                                                                                                                                     Epidermal spongiosis with superficial and deep mixed infiltrate of eosinophils, lymphocytes, and neutrophils                                                                                                 Methylprednisolone, prednisone, and high-potency topical glucocorticoids for skin lesions                                                                                                                                  Rate of resolution increased but lesions continued to recur                                                                                                                                                           [@b8-dp0703a02]
  Bari and Cohen, 2017   1                 CLL                                        59; W                5-year history of dermatomal and non-dermatomal distribution of vesicles on the back and flanks                                                                                                              Eosinophilic spongiosis, intraepidermal vesicle with eosinophils, and perivascular and periadnexal lymphocytic infiltrate with eosinophils                                                                   Acyclovir, topical betamethasone for skin lesions; CLL was treated with many agents but most recently the patient was started on obinutuzumab                                                                              Acyclovir was not efficacious, though topical betamethasone led to temporary resolution of skin lesions; patient experienced fewer recurrences after obinutuzumab was started                                         CR

Abbreviations: ALL, acute lymphocytic leukemia; AML, acute monocytic leukemia; CHOP, cyclophosphamide, hydroxydaunorubicin, oncovin, and prednisone; CLL, chronic lymphocytic leukemia; CR, current report; DLBCL, diffuse large B cell lymphoma; EDHM, eosinophilic dermatosis of hematologic malignancy; IVIG, intravenous immunoglobulin; LCL, large cell lymphoma; M, man; MCL, mantle cell lymphoma; MDS, myelodysplastic syndrome; MF, myelofibrosis; MM, multiple myeloma; NHL, non-Hodgkin lymphoma; NMZL, nodal marginal zone lymphoma; NR, not reported; Ref, reference; UV-B, ultraviolet-B phototherapy; W, woman
